Workflow
“体检十年查不出患癌风险”当事人:爱康国宾把责任推给用户,无耻
凤凰网财经·2025-07-18 11:32

Core Viewpoint - The article discusses a complaint against iKang Guobin regarding a failure to detect cancer during routine health check-ups, highlighting issues of accountability and the adequacy of their testing methods [1][2][6]. Group 1: Complaint Details - The complainant, Zhang Xiaoling, argues that iKang Guobin's response shifts all responsibility to the user, claiming that the company did not provide adequate information on the timing and methods of tests [2][3]. - Zhang Xiaoling expresses frustration over the lack of clarity regarding the detection capabilities of iKang Guobin, questioning why users should pay for health checks if potential issues are not identified [2][3]. - iKang Guobin stated that the ability to detect cancer depends on various factors, including the timing of the check-up and the methods used, but Zhang disagrees with this explanation [1][2]. Group 2: Company Response and History - iKang Guobin has publicly stated that they have contacted Zhang Xiaoling but have not taken action on her request for testing samples and imaging [4]. - The company has faced multiple complaints in recent years regarding inaccurate health reports, misdiagnoses, and negligence in testing procedures, with over 1,306 complaints recorded on a third-party platform [6]. - The ongoing controversy surrounding the alleged misdiagnosis and negligence continues to attract public attention, with further developments expected [8].